Tag: narrow therapeutic index
- April
7
2026 - 5
Why Your Doctor Might Prescribe Brand-Name Only Medications
Learn why doctors sometimes insist on brand-name medications over generics, from Narrow Therapeutic Index (NTI) safety to proprietary delivery systems.
Read More- March
9
2026 - 5
FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained
The FDA requires stricter bioequivalence standards for NTI drugs like warfarin, digoxin, and phenytoin, with tighter limits (90-111%) and scaled testing to ensure patient safety. These rules prevent dangerous variations in generic versions.
Read More